secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACCENDRA HEALTH INC/VA/ (ACH)
CIK:        0000075252
Form:       8-K
Filed at:   2025-08-11T23:59:59+00:00
Accession:  0001193125-25-177426
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Owens & Minor Q2: GAAP loss from continuing ops $83.8M; Products & Healthcare segment classified as discontinued ops
--------------------------------------------------------------------------------

- Revenue from continuing ops $681.9M, up 3% YoY from $660.4M.
- GAAP loss from continuing ops $(83.8)M vs $(6.7)M in 2Q24; adjusted net income $20.5M vs $19.3M.
- Adjusted EBITDA from continuing ops $96.6M, up 6% from $91.1M.
- Company in final stages of divestiture of Products & Healthcare Services segment; classified as discontinued ops.
- 2025 continuing ops financial outlook to be provided during 8:30 a.m. EDT earnings call.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/75252/000119312525177426/0001193125-25-177426-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/75252/000119312525177426/d47157d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-177426

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer